Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Major Study on Chelation Therapy for Heart DiseaseEDTA Chelation Therapy might become an accepted therapy for heart disease and circulation problems based on the TACT study.
TACT is a 7-year study funded by the NIH and carried out by university cardiologists and experienced chelation physicians from around the United States. This randomized, double-blind study compared patients who had previous heart attacks who were treated with medications with or without intravenous chelation therapy. The results of TACT will be presented at the American Heart Association meeting November 4, 2012 in Los Angeles. Chelation, from the Greek word “chele” meaning claw, implies that an organic molecule binds a cation (charged mineral) in a pincer-like fashion, forming a heterocyclic ring structure.The most widely accepted use of chelation therapy is for the removal of toxic minerals such as lead from the body. A more controversial indication, discovered serendipitously during treatment of patients suffering with lead toxicity involving the use of the chelating agent disodium ethylene diaminetetraacetic acid (EDTA), is in the treatment of all forms of atherosclerotic cardiovascular disease. For more information on the development of EDTA Chelation Therapy go to www.chelation.me. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|